About Us

Company size 201 to 500 Revenue £730k to £4m (GBP) Industry Biotechnology Link Oxitec Ltd website Oxitec is the leading developer of biological solutions to control pests that transmit disease, destroy crops and harm livestock. Oxitec’s mission is to save lives and improve livelihoods by developing safe, highly-effective biologically-engineered solutions to control disease-transmitting and crop-destroying insects globally. To do our work, we leverage our world-class team of scientists, engineers, public health and agricultural experts, entrepreneurs, community engagement experts and others to build safe, targeted, sustainable and highly effective genetically modified insect technologies that can be applied in the fields of public health and food security. We do our work with a commitment to safety, effectiveness, scientific integrity, and transparency, making Oxitec’s technologies one of the largest self-limiting insect platforms in the world. Oxitec’s technology has been studied and analyzed by independent researchers, academics and independent collaborators for more than a decade, with more than 100 scientific, peer-reviewed papers published on our work. You can find a sample of the growing body of scientific evidence here . With a continuing commitment to our start-up roots in Oxford, we are a wholly-owned subsidiary of Intrexon ( DNA.com ), giving us full access to an unparalleled global platform of biological engineering innovations, leadership, expertise, and resources. Our History Oxitec was formed in 2002 by Oxford University Innovation and, in 2015, was acquired by U.S.-based Intrexon. Since inception, Oxitec has pioneered work on controlling insects that spread disease and damage crops through world-class genetic engineering and the use of self-limiting gene technology. In the mid and late 2000s, Oxitec successfully deployed genetically engineered insects in select locations in the USA, Caribbean, South America, and has continued to grow these projects, expanding to new regions and countries. In 2016, the World Health Organization (WHO) issued a positive recommendation in support of Oxitec’s self-limiting mosquitoes (OX513A) for a planned pilot in response to the Zika virus outbreak. Oxitec continues to engage with communities around the world that are in need of effective, scalable solutions to combat the dangerous vectors that threaten lives and livelihoods. Oxitec is a subsidiary of Intrexon Corporation ( NASDAQ: XON) , which engineers biology to help solve some of the world’s biggest problems. *About Us * We are a team of passionate individuals, developing ground-breaking biological technologies designed to sustainably, and safely, control insects that transmit diseases and destroy crops. We do this work to improve lives and livelihoods around the world in the face of the growing threats that insects pose to human health and the global food supply. We are strongly committed to a set of values, principles, and behaviors, which foster a culture of trust, respect, creativity, and accountability - and seek talented people who are deeply committed to our mission, values, and principles, and thrive in start-up like environments. Learn more here about our mission, values, and principles.